期刊中文名:墨西哥腫瘤學(xué)公報ISSN:1665-9201
該雜志國際簡稱:GAC MEX ONCOL,是由出版商Permanyer出版的一本致力于發(fā)布--研究新成果的的專業(yè)學(xué)術(shù)期刊。主要發(fā)表刊登有創(chuàng)見的學(xué)術(shù)論文文章、行業(yè)最新科研成果,扼要報道階段性研究成果和重要研究工作的最新進(jìn)展,選載對學(xué)科發(fā)展起指導(dǎo)作用的綜述與專論,促進(jìn)學(xué)術(shù)發(fā)展,為廣大讀者服務(wù)。該刊是一本國際優(yōu)秀雜志,在國際上有很高的學(xué)術(shù)影響力。
《Gaceta Mexicana De Oncologia》是一本以Spanish/English為主的開放獲取國際優(yōu)秀期刊,中文名稱墨西哥腫瘤學(xué)公報,本刊主要出版、報道領(lǐng)域的研究動態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗和科研成果,介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展,探討行業(yè)發(fā)展的思路和方法,以促進(jìn)學(xué)術(shù)信息交流,提高行業(yè)發(fā)展。該刊已被國際權(quán)威數(shù)據(jù)庫SCIE收錄,為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動作用,也得到了本專業(yè)人員的廣泛認(rèn)可。最新CiteScore 指數(shù)為0.1。
Gaceta Mexicana De Oncolia is a professional journal of significant importance in the field of oncology. It is committed to providing the latest and most comprehensive oncology research results and clinical practice experience for medical researchers, clinical doctors, and related professionals. We also actively promote academic exchanges and cooperation between countries. It not only focuses on the progress of oncology research in Mexico, but also extensively absorbs advanced international experience and research results, contributing to the development of oncology in Mexico and even globally.
This journal covers various aspects of oncology, including basic research on tumors, clinical diagnosis, treatment methods, prevention strategies, and rehabilitation nursing. From the common types of cancer such as lung cancer, breast cancer, gastric cancer, to rare tumor diseases, there are in-depth discussions and studies. For example, in terms of basic research, journals may publish new discoveries about the biological mechanisms of tumor cells, providing theoretical basis for the development of new therapeutic targets; In the field of clinical diagnosis, introduce the application of advanced imaging techniques and biomarkers in early diagnosis of tumors.
按JIF指標(biāo)學(xué)科分區(qū) |
學(xué)科:ONCOLOGY
收錄子集:ESCI
分區(qū):Q4
排名:322 / 322
百分位:
0.2% |
按JCI指標(biāo)學(xué)科分區(qū) |
學(xué)科:ONCOLOGY
收錄子集:ESCI
分區(qū):Q4
排名:322 / 322
百分位:
0.16% |
JCR分區(qū):JCR分區(qū)來自科睿唯安公司,JCR是一個獨(dú)特的多學(xué)科期刊評價工具,為唯一提供基于引文數(shù)據(jù)的統(tǒng)計信息的期刊評價資源。每年發(fā)布的JCR分區(qū),設(shè)置了254個具體學(xué)科。JCR分區(qū)根據(jù)每個學(xué)科分類按照期刊當(dāng)年的影響因子高低將期刊平均分為4個區(qū),分別為Q1、Q2、Q3和Q4,各占25%。JCR分區(qū)中期刊的數(shù)量是均勻分為四個部分的。
學(xué)科類別 | 分區(qū) | 排名 | 百分位 |
大類:Medicine 小類:Oncology | Q4 | 390 / 404 |
3% |
大類:Medicine 小類:Cancer Research | Q4 | 224 / 230 |
2% |
該雜志是一本國際優(yōu)秀雜志,在國際上有較高的學(xué)術(shù)影響力,行業(yè)關(guān)注度很高,已被國際權(quán)威數(shù)據(jù)庫SCIE收錄,該雜志在綜合專業(yè)領(lǐng)域?qū)I(yè)度認(rèn)可很高,對稿件內(nèi)容的創(chuàng)新性和學(xué)術(shù)性要求很高,作為一本國際優(yōu)秀雜志,一般投稿過審時間都較長,投稿過審時間平均 40 Weeks ,如果想投稿該刊要做好時間安排。版面費(fèi)不祥。該雜志近兩年未被列入預(yù)警名單,建議您投稿。如您想了解更多投稿政策及投稿方案,請咨詢客服。
若用戶需要出版服務(wù),請聯(lián)系出版商。